2025-12-18 22:20:33

PETV has been following the traditional path of medical devices for over twenty years, and only recently launched an AI diagnostic platform—equipping veterinarians with intelligent agent tools to assist in pet diagnosis. This direction is indeed new, but what does Wall Street think? Currently, the valuation is still based on traditional medical devices, with a market cap around $45 million. In other words, the valuation multiple people are assigning is in the 1-2x range. Is there an undervaluation opportunity here, or is the market still cautious about the potential of AI diagnostic platforms? It's worth pondering.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

18 Likes

Reward
18
10
Repost
Share

Comment

0/400

ProposalManiac

· 2025-12-21 21:50

Underestimation or caution, the key is to see how the balance of the game in the veterinary market is built. Valuing traditional medical devices based on AI tools indicates that the market is still waiting for proof—this is not condescension, but a necessary caution in governance logic. The number of 1-2 times is not questionable, the problem is whether PETV's incentive mechanism is clear: if doctors use AI for diagnosis, can patient trust increase? This is the anchor of long-term value. Looking at the historical lessons from the digital health wave, those with high valuations that collapsed all ignored the real adoption costs of practitioners. For PETV to leverage the veterinary community, it must first design a well-aligned incentive mechanism. We cannot just look at the surface of underestimation; we need to ask whether it has thought through these issues in its proposals.

View OriginalReply0

GasFeeNightmare

· 2025-12-20 09:08

45 million valuation, 1-2x multiple? Isn't this just the market not understanding how much AI diagnostics are worth, or still thinking the risk is high and pushing down the price... Late at night, I start thinking about these low-liquidity assets again, really a cost-saving and loss-making rhythm

View OriginalReply0

MultiSigFailMaster

· 2025-12-19 22:19

Still valuing at 45 million USD using the old methods? These VCs must be so conservative. No one really seems optimistic about AI diagnostics.

View OriginalReply0

blockBoy

· 2025-12-19 20:52

Speaking of which, the $45 million valuation is really impressive. AI diagnostics are already here, yet they still follow the old routines to fund it. Wall Street folks are truly conservative.

View OriginalReply0

rugpull_ptsd

· 2025-12-18 22:50

Even dogs are diagnosed, but we still haven't figured it out. This valuation multiple is way too disappointing...

View OriginalReply0

GateUser-afe07a92

· 2025-12-18 22:49

This valuation is really conservative; Wall Street is conservative too. Even with AI diagnostics coming, they still value it at the same multiple as traditional medical devices? It does seem truly undervalued.

View OriginalReply0

ContractTester

· 2025-12-18 22:48

45 million valuation for AI diagnostic platform? This market is really conservative to an absurd degree, still using traditional equipment to do the math.

View OriginalReply0

HalfIsEmpty

· 2025-12-18 22:48

What are you underestimating? Isn't it just that the market's imagination for pet healthcare is limited?

View OriginalReply0

GasFeePhobia

· 2025-12-18 22:41

Estimated at 45 million? That's really a bit outrageous... Is the veterinary AI sector truly underestimated, or does the market just not believe in this approach?

View OriginalReply0

LiquidityWitch

· 2025-12-18 22:27

ngl, PETV's been sleeping on the alchemy thing for 20 years... now suddenly brewing AI spells for vet clinics? 1-2x multiples screams either forbidden arbitrage or the market's just being dense about transmutation potential tbh

Reply0